Evidence map›Paper›PMID 41366866›Full record

ArticleThe plant pathology journal2025

Antagonistic Activity and Genomic Insights of Bacillus velezensis JE250 against Erwinia amylovora.

Jueun Lee, Won-Kwon Jung, Hee-Young Jung, Yong Chull Jeun, Yongho Jeon, Hyong Woo Choi

Abstract read
In one paragraph

Article in The plant pathology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jueun LeeDepartment of Plant Medicals, GyeongKuk National University, Andong 36729, Korea.
Won-Kwon JungGyeongsangbuk-do Agricultural Research & Extension Services, Daegu 41404, Korea.
Hee-Young JungDepartment of Plant Medicine, Kyungpook National University, Daegu 41566, Korea.
Yong Chull JeunSustainable Agriculture Research Institute, Jeju National University, Jeju 63243, Korea.
Yongho JeonDepartment of Plant Medicals, GyeongKuk National University, Andong 36729, Korea.
Hyong Woo ChoiDepartment of Plant Medicals, GyeongKuk National University, Andong 36729, Korea.

Funding

Gyeongsangbuk-do Basic Project LP0052262024
6 · The paper itself

Abstract

Fire blight, caused by Erwinia amylovora, is a highly destructive bacterial disease that affects apple and pear orchards worldwide, leading to significant economic losses. In this study, we isolated and characterized endophytic bacterial strains from apple trees in Gyeongsangbuk-do, South Korea, to identify potential biocontrol agents against E. amylovora. Among the five antagonistic strains identified, Bacillus velezensis JE80 and JE250 exhibited the strongest inhibitory effects. Further analysis using culture filtrates (CFs) from these strains demonstrated that the CFs of JE80 and JE250 not only suppressed E. amylovora growth in a growth-phase-dependent manner but also significantly impaired bacterial motility and biofilm formation. Notably, in planta assays revealed that JE250 effectively reduced fire blight symptoms in apple blossoms, performing comparably to streptomycin sulfate. Whole-genome sequencing of JE250 identified biosynthetic gene clusters associated with the production of antimicrobial compounds, including difficidin, fengycin, bacillaene, macrolactin, bacillibactin, and bacilysin, further supporting its strong antagonistic potential. These findings suggest that B. velezensis JE250 is a promising biocontrol agent for sustainable fire blight management. Future research should focus on optimizing formulation methods for field application, characterizing specific antimicrobial compounds, and evaluating its long-term efficacy in orchard environments.

Indexed as

antimicrobial compoundsBacillus velezensisbiological controlErwinia amylovorafire blight

Identifiers

PMID41366866
PMCPMC12690259

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.